Physical and mental health complications post-COVID-19: Scoping review

Shanbehzadeh, Sanaz; Tavahomi, Mahnaz; Zanjari, Nasibeh; Ebrahimi, Ismaeil; Amiri-arimi, Somayeh

doi:10.1016/j.jpsychores.2021.110525

Cited by 187 publications

(188 citation statements)

References 69 publications

Supporting

Mentioning

153

Contrasting

Unclassified

Order By: Relevance

“…Complications and reported symptoms here are concordant with the post-COVID-19 disease despite a mild illness in most patients. Hair loss, fatigue, smell/taste loss, headache, muscle pain, insomnia, and anxiety symptoms agree with the post-COVID-19 disease definition [48,49]. In general, physical symptoms (fatigue, muscle pain, headache, lost smell/taste, and vision disorder) had a higher incidence in the B group than mental symptoms (anxiety, depression, insomnia) when compared with other ABO.…”

Section: Discussionsupporting

confidence: 71%

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

Domènech-Montoliu¹,

Puig-Barberà

Pac-Sa³

et al. 2021

IJERPH

View full text Add to dashboard Cite

After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results.

show abstract

Section: Discussionsupporting

confidence: 71%

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

Domènech-Montoliu¹,

Puig-Barberà

Pac-Sa³

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…Recent reviews have investigated the neuropsychiatric sequelae of COVID-19, but to our knowledge, none have reported on the frequency of depression, specifically, in accordance with NICE-defined post-COVID-19 syndrome ( Shanbehzadeh et al, 2021 ; Sinanović, 2021 ; Vanderlind et al, 2021 ). Notwithstanding, studies reporting on the survivors of the severe acute respiratory syndrome (SARS) pandemic in 2003 have indicated the presence of depression for up to 12 months following hospital discharge ( Liu et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

Renaud-Charest

Lui

Eskander

et al. 2021

Journal of Psychiatric Research

235

164

View full text Add to dashboard Cite

Following recovery from COVID-19, an increasing proportion of individuals have reported the persistence and/or new onset of symptoms which collectively have been identified as post-COVID-19 syndrome by the National Institute for Health and Care Excellence. Although depressive symptoms in the acute phase of COVID-19 have been well characterized, the frequency of depression following recovery of the acute phase remains unknown. Herein, we sought to determine the frequency of depressive symptoms and clinically-significant depression more than 12 weeks following SARS-CoV-2 infection. A systematic search of PubMed, Ovid Medline and Google Scholar for studies published between 1 January 2020 and 5 June 2021 was conducted. Frequency and factors associated with depression in post-COVID-19 syndrome were recorded and qualitatively assessed through narrative synthesis. Methodological quality and risk of bias was assessed using a modified version of the Newcastle-Ottawa Scale (NOS) for prospective cohort studies. Of 316 articles identified through our systematic search, eight studies were included. The frequency of depressive symptoms +12 weeks following SARS-CoV-2 infection ranged from 11-28%. The frequency of clinically-significant depression and/or severe depressive symptoms ranged from 3-12%. The severity of acute COVID-19 was not associated with the frequency of depressive symptoms. However, the component studies were highly heterogeneous with respect to mode of ascertainment, time of assessment, and location and age of patients. The majority of studies did not include an unexposed control group. Future research should endeavour to produce a standardized classification of post-COVID-19 syndrome, and as well as include unexposed control groups.

show abstract

“…One metaanalysis conducted in Asian countries during the COVID-19 crisis showed that more than 20% of people developed anxiety and depression (4). Evidence suggests that the symptoms of anxiety and depression (16-28%) and self-reported stress (8%), are common psychological reactions to COVID-19 infection (5)(6)(7). Studies have also shown an increase in the incidence of feelings of anger, fear-avoidance behaviors, and symptoms of post-traumatic stress disorder (PTSD) (8,9).…”

Section: Introductionmentioning

confidence: 99%

The Prevalence of Post-traumatic Stress Disorder Among Health Care Workers During the COVID-19 Pandemic: An Umbrella Review and Meta-Analysis

et al. 2021

View full text Add to dashboard Cite

Introduction: Frontline health care workers (HCWs) have had an increased risk of developing health problems during the COVID-19 pandemic. In addition to physical illness, they have experienced mental health challenges, including post-traumatic stress disorder (PTSD). The aim of this study is to investigate the prevalence of PTSD among HCWs during the COVID-19 pandemic via an umbrella review and meta-analysis.Methods: This study was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline to perform a systematic literature search using various medical databases (Web of science, PubMed, Scopus, Cochrane, ProQuest, Science Direct, Embase, and Google scholar). The search included all articles published through the first of January 2020 the end of March 2021. The systematic review and meta-analysis studies that reported the prevalence of PTSD among health care workers were included in the study, and studies that reported the prevalence of PTSD in normal people or other epidemics were excluded. The random effects model was used to perform a meta-analysis, and the I2 index was used to evaluate heterogeneity among studies. Publication bias was assessed using the Egger test. Data was analyzed using STATA (version 14) software.Results: The initial literature search yielded 145 studies. After excluding duplicates and assessing the quality of the studies, 7 studies were selected for meta-analysis. The results showed that the overall prevalence of PTSD among HCWs during the COVID-19 pandemic was 13.52% (95% CI: 9.06–17.98, I2 = 65.5%, p = 0.008).Conclusion: There is a high prevalence of PTSD among frontline HCWs during the COVID-19 pandemic. It is important to invest in efforts to screen HCWs for mental health disorders such as PTSD and provide them with mental health support.

show abstract

Physical and mental health complications post-COVID-19: Scoping review

Cited by 187 publications

References 69 publications

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

The Prevalence of Post-traumatic Stress Disorder Among Health Care Workers During the COVID-19 Pandemic: An Umbrella Review and Meta-Analysis

Contact Info

Product

Resources

About